CMS has released a proposed rule setting eligibility requirements for a new law offering immunosuppressive drug coverage for more patients with a kidney transplant.
Congress approved the expanded coverage in December 2020. The rule would take effect in January.
Patients diagnosed with end-stage kidney disease who are older than 65 years automatically receive lifetime immunosuppressive drug coverage from Medicare if they received a kidney transplant. However, when an individual younger than 65 years old receives a kidney transplant, Medicare coverage ends 3 years after unless the individual is